Effects of Circadian Rhythm on Glycemic Regulation During Continuous Moderate Exercise and Intense Intermittent Disease in Adolescents Living With Type 1 Diabetes
NCT ID: NCT06803446
Last Updated: 2025-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
18 participants
INTERVENTIONAL
2024-12-18
2026-12-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Physical Activity on Blood Glucose Stability and Energy Stores in Individuals With Type 1 Diabetes
NCT02068638
Insulin-based Strategies to Prevent Hypoglycemia During Exercise
NCT03349489
Impact of Objective Sleep Duration on Blood Glucose Control in Type 1 Diabetes Adult Patients
NCT01017965
Validation of Algorithms for Basal Insulin Rate Reductions in Type 1 Diabetic Patients Practising Physical Activity
NCT01277965
Suspending Basal Insulin Levels for Exercise in Adults With Type 1 Diabetes
NCT03034798
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
* Continuous exercise on ergocycle in the morning
* Continuous exercise on ergocycle in the afternoon
* Intermittent exercise on ergocycle in the morning
* Intermittent exercice on ergocycle in the afternoon
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Continuous - morning
Continuous exercise on ergocycle in the morning
No interventions assigned to this group
Continuous - afternoon
Continuous exercise on ergocycle in the afternoon
physical test
continuous and intermittent exercise on cycloergometer
Intermittent - morning
Intermittent exercise on ergocycle in the morning
No interventions assigned to this group
Intermittent - afternoon
Intermittent exercice on ergocycle in the afternoon
physical test
continuous and intermittent exercise on cycloergometer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
physical test
continuous and intermittent exercise on cycloergometer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Living with type 1 diabetes for at least 1 year with HbA1c less than or equal to 12%;
* Socially insured ;
* Having given their written consent to participate in the research, as well as that of their legal guardians;
* Willing to comply with all research procedures and duration.
Exclusion Criteria
* Recent acute macrovascular event (\< 3 months), e.g. acute coronary syndrome or cardiac surgery;
* Abnormal blood picture and/or anemia;
* Current pregnancy;
* Other serious medical condition likely to interfere with study participation or ability to complete exercise periods in the judgment of the investigator (e.g., orthopedic limitation);
* Inability to receive informed information;
* Inability to participate in the entire study;
* Lack of social security coverage;
* Refusal to sign the consent form.
10 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lille University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eurasport
Loos, Nord, France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D2024-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.